Ashwani Verma
Stock Analyst at UBS
(1.28)
# 1867
Out of 5,370 analysts
78
Total ratings
47.22%
Success rate
3.08%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALKS Alkermes | Upgrades: Buy | 33 42 | 30.39 | 38.2% | 5 | Jun 17, 2025 | |
INCY Incyte | Maintains: Neutral | 61 61 | 70.43 | -13.39% | 1 | Jun 3, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 137 152 | 124.86 | 21.74% | 8 | May 6, 2025 | |
CYTK Cytokinetics | Maintains: Neutral | 47 41 | 33.35 | 22.94% | 5 | May 2, 2025 | |
HRMY Harmony Biosciences ... | Maintains: Buy | 55 48 | 32.74 | 46.61% | 2 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 22 | 22.23 | -1.03% | 4 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 0.76 | 38.16% | 5 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 179 | 108.53 | 64.93% | 6 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 17.07 | 58.17% | 8 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 34 | 41.76 | -18.58% | 2 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 9.37 | 49.41% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 286.37 | 65.87% | 4 | Jan 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 64.69 | 76.23% | 2 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 15.01 | 259.76% | 3 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | n/a | n/a | 5 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 100.33 | 4.65% | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 34.83 | -19.61% | 3 | Jun 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 34.49 | 134.85% | 2 | Mar 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 81.56 | -91.42% | 1 | Aug 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.88 | 35.14% | 2 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 0.55 | 2627.27% | 1 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |